These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16075919)

  • 41. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
    De Bellis A; Sansone D; Coronella C; Conte M; Iorio S; Perrino S; Battaglia M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Graves' ophthalmopathy: pathogenesis and clinical implications.
    Major BJ; Busuttil BE; Frauman AG
    Aust N Z J Med; 1998 Feb; 28(1):39-45. PubMed ID: 9544385
    [No Abstract]   [Full Text] [Related]  

  • 43. Graves' ophthalmopathy. A clinical and immunologic review.
    Sergott RC; Glaser JS
    Surv Ophthalmol; 1981; 26(1):1-21. PubMed ID: 6895125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenesis of Graves' ophthalmopathy.
    Spitzweg C; Heufelder AE
    Int Arch Allergy Immunol; 1997 Sep; 114(1):101-2. PubMed ID: 9303340
    [No Abstract]   [Full Text] [Related]  

  • 45. Detectable serum IgE levels in Graves' ophthalmopathy.
    Molnár I; Horváth S; Balázs C
    Eur J Med Res; 1996 Sep; 1(11):543-6. PubMed ID: 9438158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Graves' hyperthyroidism and endocrine ophthalmopathy--one or two closely related diseases?
    Volpé R
    Dev Ophthalmol; 1993; 25():101-11. PubMed ID: 8359344
    [No Abstract]   [Full Text] [Related]  

  • 47. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
    Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
    J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum levels of soluble Fas in patients with Graves' ophthalmopathy.
    Ohtsuka K; Hashimoto M
    Br J Ophthalmol; 2000 Jan; 84(1):103-6. PubMed ID: 10611108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies.
    McLachlan SM; Bahn R; Rapoport B
    Autoimmunity; 1992; 14(2):143-8. PubMed ID: 1363894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on the occurrence of ophthalmopathy in Graves' disease.
    Marcocci C; Bartalena L; Bogazzi F; Panicucci M; Pinchera A
    Acta Endocrinol (Copenh); 1989 Apr; 120(4):473-8. PubMed ID: 2718699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A 64 kDa membrane antigen is a recurrent epitope for natural autoantibodies in patients with Graves' thyroid and ophthalmic diseases.
    Kendler DL; Rootman J; Huber GK; Davies TF
    Clin Endocrinol (Oxf); 1991 Dec; 35(6):539-47. PubMed ID: 1722742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy.
    Nishikawa M; Yoshimura M; Toyoda N; Masaki H; Yonemoto T; Gondou A; Kato T; Kurokawa H; Furumura T; Inada M
    Acta Endocrinol (Copenh); 1993 Sep; 129(3):213-9. PubMed ID: 8105634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leukocyte migration test for the study of immune reactivity in cases of Graves disease associated with infiltrative ophthalmopathy.
    Kálmán K; Erdei I; Sándor P; Fazakas S; Leövey A
    Acta Med Acad Sci Hung; 1978; 35(1):29-34. PubMed ID: 581631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
    Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
    Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cellular and humoral autoimmune responses against human eye muscle membrane antigen in Graves' disease.
    Molnár I; Németi K; Bokk A; Stenszky V; Balázs C; Farid NR
    Acta Med Hung; 1990; 47(1-2):43-51. PubMed ID: 2280995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alpha-fodrin as a putative autoantigen in Graves' ophthalmopathy.
    Kahaly GJ; Bang H; Berg W; Dittmar M
    Clin Exp Immunol; 2005 Apr; 140(1):166-72. PubMed ID: 15762888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study.
    Marcocci C; Bruno-Bossio G; Manetti L; Tanda ML; Miccoli P; Iacconi P; Bartolomei MP; Nardi M; Pinchera A; Bartalena L
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):503-8. PubMed ID: 10583319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy.
    Gamblin GT; Harper DG; Galentine P; Buck DR; Chernow B; Eil C
    N Engl J Med; 1983 Feb; 308(8):420-4. PubMed ID: 6687400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.